The 4th Next-Generation Conjugates Summit covers topics such as:
- Overcoming Limitations With Traditional ADCs With Novel Technology
- Surveying the Scope of Novel Payload Development for Improved Targeted Cell-Killing/center>
- Designing Improved Manufacturing Strategies to Streamline Your Next-Generation Conjugate Development
- Diversifying Novel Formats for More Unique Development Beyond Traditional Monoclonal Antibodies
- Safely Advancing Into the Clinic: Dosage Considerations With Non-Traditional Conjugates
- Clinical Data Success Stories: How is the Next-Generation Conjugate Field Progressing & What Have We Learned?
- Regulatory Hurdles in Next-Generation Conjugates to Best Prepare for IND & BLA Applications
- Novel Formats in Conjugated Cancer Therapies for Maximum Safety & Efficacy
- Navigating Novel Formats for Conjugates: What are the Benefits of Going Beyond ADCs?
- Diversifying the Scope of Available Targets With Novel Technologies Beyond Monoclonal Antibodies & Traditional Payloads
The 4th Next-Generation Conjugates Summit might be held in Boston, United States in Feb 2025.
